Cargando…

Hepatitis B/C in the countries of the EU/EEA: a systematic review of the prevalence among at-risk groups

BACKGROUND: In 2016, the World Health Organisation set a goal to eliminate viral hepatitis by 2030. Robust epidemiological information underpins all efforts to achieve elimination and this systematic review provides estimates of HBsAg and anti-HCV prevalence in the European Union/European Economic A...

Descripción completa

Detalles Bibliográficos
Autores principales:	Falla, Abby May, Hofstraat, Sanne Henrietta Ina, Duffell, Erika, Hahné, Susan Josien Maria, Tavoschi, Lara, Veldhuijzen, Irene Karen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5809955/ https://www.ncbi.nlm.nih.gov/pubmed/29433454 http://dx.doi.org/10.1186/s12879-018-2988-x

Ejemplares similares

Current prevalence of chronic hepatitis B and C virus infection in the general population, blood donors and pregnant women in the EU/EEA: a systematic review
por: HOFSTRAAT, S. H. I., et al.
Publicado: (2017)

Estimating the scale of chronic hepatitis B virus infection among migrants in EU/EEA countries
por: Ahmad, Amena A., et al.
Publicado: (2018)

Hepatitis B and C prevalence and incidence in key population groups with multiple risk factors in the EU/EEA: a systematic review
por: Mason, Lauren MK, et al.
Publicado: (2019)

Hepatitis B and C testing strategies in healthcare and community settings in the EU/EEA: A systematic review
por: Mason, Lauren M. K., et al.
Publicado: (2019)

Hepatitis C virus infection in EU/EEA and United Kingdom prisons: opportunities and challenges for action
por: Nakitanda, Aya Olivia, et al.
Publicado: (2020)

Hepatitis B virus infection in EU/EEA and United Kingdom prisons: a descriptive analysis
por: Nakitanda, Aya Olivia, et al.
Publicado: (2021)

Correction to: Hepatitis C virus infection in EU/EEA and United Kingdom prisons: Opportunities and challenges for action
por: Nakitanda, Aya Olivia, et al.
Publicado: (2023)

Estimating the scale of chronic hepatitis C virus infection in the EU/EEA: a focus on migrants from anti-HCV endemic countries
por: Falla, A. M., et al.
Publicado: (2018)

Monitoring of HIV testing services in the EU/EEA
por: Tavoschi, Lara, et al.
Publicado: (2016)

Monitoring progress towards elimination of hepatitis B and C in the EU/EEA
por: Sharrock, Katherine C., et al.
Publicado: (2022)

Correction: Monitoring progress towards elimination of hepatitis B and C in the EU/EEA
por: Sharrock, Katherine C., et al.
Publicado: (2023)

Estimates of hepatitis B virus prevalence among general population and key risk groups in EU/EEA/UK countries: a systematic review
por: Bivegete, Sandra, et al.
Publicado: (2023)

Viral hepatitis micro-elimination: models of care and barriers to implementation in 5 EU/EEA prisons
por: Seyler, T, et al.
Publicado: (2022)

Healthcare-associated hepatitis B and C transmission to patients in the EU/EEA and UK: a systematic review of reported outbreaks between 2006 and 2021
por: Singh, Jasleen, et al.
Publicado: (2022)

Hepatitis A notifications in the EU/EEA, 2010–2019: what can we learn from case reporting to the European Surveillance System?
por: Severi, Ettore, et al.
Publicado: (2023)

The Effectiveness and Cost-Effectiveness of Hepatitis C Screening for Migrants in the EU/EEA: A Systematic Review
por: Greenaway, Christina, et al.
Publicado: (2018)

Is EU/EEA population protected from polio?
por: Nijsten, DRE, et al.
Publicado: (2015)

Hepatitis B and C among healthcare workers and patient groups at increased risk of iatrogenic transmission in the European Union/European Economic Area
por: Tavoschi, L., et al.
Publicado: (2019)

The Effectiveness and Cost-Effectiveness of Screening for and Vaccination Against Hepatitis B Virus among Migrants in the EU/EEA: A Systematic Review
por: Myran, Daniel T, et al.
Publicado: (2018)

Legionnaires’ disease in the EU/EEA*: increasing trend from 2017 to 2019
por: Samuelsson, Jonas, et al.
Publicado: (2023)

Upsurge in echovirus 30 detections in five EU/EEA countries, April to September, 2018
por: Broberg, Eeva K, et al.
Publicado: (2018)

Measles Immunization Policies and Vaccination Coverage in EU/EEA Countries over the Last Decade
por: Montalti, Marco, et al.
Publicado: (2020)

Comparison, by Country, of the Uptake of COVID-19 Vaccination by Health Care Workers in the EU/EEA
por: McGlacken, T, et al.
Publicado: (2023)

Reply: Tuberculosis screening in migrants to the EU/EEA and UK
por: Zenner, Dominik, et al.
Publicado: (2023)

Immunisation Information Systems – useful tools for monitoring vaccination programmes in EU/EEA countries, 2016
por: Derrough, Tarik, et al.
Publicado: (2017)

Trends in the hospital-sector consumption of the WHO AWaRe Reserve group antibiotics in EU/EEA countries and the United Kingdom, 2010 to 2018
por: Benkő, Ria, et al.
Publicado: (2022)

Reducing burden from respiratory infections in refugees and immigrants: a systematic review of interventions in OECD, EU, EEA and EU-applicant countries
por: Lambert, Jan-Frederic, et al.
Publicado: (2021)

HIV testing strategies employed in health care settings in the European Union/European Economic Area (EU/EEA): evidence from a systematic review
por: Desai, S, et al.
Publicado: (2019)

Spatiotemporal spread of tick-borne encephalitis in the EU/EEA, 2012 to 2020
por: Van Heuverswyn, Jasper, et al.
Publicado: (2023)

The role of the general practitioner in the screening and clinical management of chronic viral hepatitis in six EU countries
por: Bechini, A., et al.
Publicado: (2016)

Rapid risk assessment from ECDC: Resurgence of reported cases of COVID-19 in the EU/EEA, the UK and EU candidate and potential candidate countries
Publicado: (2020)

Prevalence of hepatitis C infection among the general population and high-risk groups in the EU/EEA: a systematic review update
por: Han, Ru, et al.
Publicado: (2019)

Surveillance of Zika virus infection in the EU/EEA, June 2015 to January 2017
por: Spiteri, G, et al.
Publicado: (2017)

Avian influenza overview – update on 19 November 2020, EU/EEA and the UK
por: Adlhoch, Cornelia, et al.
Publicado: (2020)

Epidemiology, surveillance and diagnosis of Usutu virus infection in the EU/EEA, 2012 to 2021
por: Angeloni, Giorgia, et al.
Publicado: (2023)

Screening for Infectious Diseases among Newly Arrived Migrants in EU/EEA Countries—Varying Practices but Consensus on the Utility of Screening
por: Kärki, Tommi, et al.
Publicado: (2014)

The Effectiveness and Cost-Effectiveness of Screening for HIV in Migrants in the EU/EEA: A Systematic Review
por: Pottie, Kevin, et al.
Publicado: (2018)

Decrease in community antibiotic consumption during the COVID-19 pandemic, EU/EEA, 2020
por: Högberg, Liselotte Diaz, et al.
Publicado: (2021)

Increasing number of cases and outbreaks caused by Candida auris in the EU/EEA, 2020 to 2021
por: Kohlenberg, Anke, et al.
Publicado: (2022)

HIV testing strategies outside of health care settings in the European Union (EU)/European Economic Area (EEA): a systematic review to inform European Centre for Disease Prevention and Control guidance
por: Croxford, S, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_jgapbihi6s5fd97uo8msoncvfe